Table 2.
Total group (n = 182) | CD (n = 123) | UC (n = 49) | IC (n = 10) | |
---|---|---|---|---|
Age (mean, IQR) | 41.9 (31,52) | 40.3 (30.0,49.5) | 44.2 (34.0,54.0) | 50.1 (37.3,68.5) |
(range) | (19,77) | (19,71) | (21,77) | (23,73) |
Race | ||||
|
136 (74.7%) | 91 (74.0%) | 36 (73.5%) | 9 (90.0%) |
|
34 (18.7%) | 24 (19.5%) | 9 (18.4%) | 1 (10.0%) |
|
8 (4.4%) | 5 (4.1%) | 3 (6.1%) | 0 (0%) |
|
4 (1.1%) | 3 (2.4%) | 1 (2.0%) | 0 (0%) |
Sex (female) | 88 (48.4%) | 62 (50.4%) | 21 (42.9%) | 5 (50.0%) |
Gender (female) | 89 (48.9%) | 62 (50.4%) | 22 (44.9%) | 5 (50.0%) |
Completed colonoscopy | 178 (97.8%) | 120 (97.6%) | 48 (98%) | 10 (100%) |
Inflammation on colonoscopy | 78 (42.9%) | 55 (44.8%) | 21 (42.9%) | 1 (10%) |
IBD-associated arthritis | ||||
|
53 (29.1%) | 41 (33.3%) | 7 (14.3%) | 5 (50.0%) |
|
110 (60.4%) | 68 (55.3%) | 38 (77.6%) | 4 (40.0%) |
|
19 (10.4%) | 14 (11.4%) | 4 (8.2%) | 1 (10.0%) |